...
首页> 外文期刊>Clinical and translational science. >Bioengineered Corneas Grafted as Alternatives to Human Donor Corneas in Three High-Risk Patients
【24h】

Bioengineered Corneas Grafted as Alternatives to Human Donor Corneas in Three High-Risk Patients

机译:生物工程角膜移植替代三位高危患者的人类供体角膜

获取原文
获取原文并翻译 | 示例

摘要

Corneas with severe pathologies have a high risk of rejection when conventionally grafted with human donor tissues. In this early observational study, we grafted bioengineered corneal implants made from recombinant human collagen and synthetic phosphorylcholine polymer into three patients for whom donor cornea transplantation carried a high risk of transplant failure. These patients suffered from corneal ulcers and recurrent erosions preoperatively. The implants provided relief from pain and discomfort, restored corneal integrity by promoting endogenous regeneration of corneal tissues, and improved vision in two of three patients. Such implants could in the future be alternatives to donor corneas for high-risk patients, and therefore, merits further testing in a clinical trial.
机译:当常规地与人类供体组织移植时,具有严重病理的角膜具有很高的排斥风险。在这项早期的观察性研究中,我们将由重组人胶原蛋白和合成磷酸胆碱聚合物制成的生物工程角膜植入物移植到了三名患者中,这些患者的供体角膜移植存在移植失败的高风险。这些患者术前患有角膜溃疡和复发性糜烂。植入物可缓解疼痛和不适,可通过促进角膜组织的内源性再生来恢复角膜完整性,并改善三分之二的患者的视力。此类植入物将来可能会替代高危患者的供体角膜,因此,值得在临床试验中进行进一步测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号